AZTREONAM

SynDRA canonical compound SYN0002136 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	bacterial septicemia \| gynecologic infections \| intra-abdominal infections \| respiratory tract infections \| skin infections \| urinary tract infections
Disease area	infectious disease

All known targets

cayston
azonam
azthreonam
aztreon
monobactam
nebactam
primbactam
aztreonam lysine
azactam
Azonam
Aztreon
Nebactam
Primbactam
NSC-646279
NSC-758913
SO 26776
SQ-26776
Azactam
Azactam (TN)
Monobactam, SQ 26776, Squibb 26776, Aztreonam
[2S-[2alpha,3beta(Z)]]-2-[[[1-(2-Amino-4-thiazolyl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid
2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl)-2-{[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino}-2-oxoethylidene]amino}oxy)-2-methylpropanoic acid
2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid
GS-9268
Aztreonam lysine
Azthreonam
rel-Aztreonam
NSC646279
CHEMBL158
Aztreonam E-Isomer
MFCD00072145
G2B4VE5GH8
CHEBI:161680
Squibb 26776
SR-01000841814
2-[[(Z)-[1-(2-Amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropionic Acid
Aztreonam (Azactam, Cayston)
Azetreonam